Riociguat: A Novel New Drug for Treatment of Pulmonary Hypertension

Acute Hemodynamic Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Diastolic Heart Failure (DILATE-1)

(2014) Diana Bonderman et al.   CHEST

Pharmacologic Therapy for Pulmonary Arterial Hypertension in Adults

(2014) Darren B. Taichman et al.   CHEST

STARTS-2

(2014) Robyn J. Barst et al.   CIRCULATION

Riociguat for Patients With Pulmonary Hypertension Caused by Systolic Left Ventricular Dysfunction

(2013) Diana Bonderman et al.   CIRCULATION

Pulmonary Hypertension in Chronic Lung Diseases

(2013) Werner Seeger et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Pulmonary Hypertension Due to Left Heart Diseases

(2013) Jean-Luc Vachiéry et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Chronic Thromboembolic Pulmonary Hypertension

(2013) Nick H. Kim et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Updated Clinical Classification of Pulmonary Hypertension

(2013) Gerald Simonneau et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension

(2013) Tomás Pulido et al.   NEW ENGLAND JOURNAL OF MEDICINE

Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension

(2013) Hossein-Ardeschir Ghofrani et al.   NEW ENGLAND JOURNAL OF MEDICINE

Riociguat for the Treatment of Pulmonary Arterial Hypertension

(2013) Hossein-Ardeschir Ghofrani et al.   NEW ENGLAND JOURNAL OF MEDICINE

The 6-Minute Walk Test in Pulmonary Arterial Hypertension

(2012) Lewis J. Rubin   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The Minimal Important Difference in the 6-Minute Walk Test for Patients with Pulmonary Arterial Hypertension

(2012) Stephen C. Mathai et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Validation of the 6-Minute Walk in Patients With Pulmonary Arterial Hypertension

(2012) Harrison W. Farber   CIRCULATION

Validation of 6-Minute Walk Distance as a Surrogate End Point in Pulmonary Arterial Hypertension Trials

(2012) Nicole B. Gabler et al.   CIRCULATION

Left ventricular systolic dysfunction associated with pulmonary hypertension riociguat trial (LEPHT): rationale and design

(2012) Stefano Ghio et al.   EUROPEAN JOURNAL OF HEART FAILURE

Riociguat for interstitial lung disease and pulmonary hypertension: a pilot trial

(2012) Marius M. Hoeper et al.   EUROPEAN RESPIRATORY JOURNAL

Practical Considerations for the Pharmacotherapy of Pulmonary Arterial Hypertension

(2012) Bryan M. Bishop et al.   PHARMACOTHERAPY

Longitudinal Follow-Up of Six-Minute Walk Distance After Pulmonary Endarterectomy

(2011) Mart N. van der Plas et al.   ANNALS OF THORACIC SURGERY

Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease

(2011) Johannes-Peter Stasch et al.   CIRCULATION

Survival in Pulmonary Arterial Hypertension: A Brief Review of Registry Data

(2011) Sunil Pauwaa et al.   Pulmonary Circulation

Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study

(2010) H. A. Ghofrani et al.   EUROPEAN RESPIRATORY JOURNAL

Riociguat (BAY 63-2521) and Warfarin: A Pharmacodynamic and Pharmacokinetic Interaction Study

(2010) Reiner Frey et al.   JOURNAL OF CLINICAL PHARMACOLOGY

First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension

(2009) F. Grimminger et al.   EUROPEAN RESPIRATORY JOURNAL

ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

(2009) Vallerie V. McLaughlin et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Chronic Thromboembolic Pulmonary Hypertension

(2009) William Auger et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Acute hemodynamic response to single oral doses of BAY 60-4552, a soluble guanylate cyclase stimulator, in patients with biventricular heart failure

(2009) Veselin Mitrovic et al.   BMC Pharmacology & Toxicology

Long-term Use of Sildenafil in Inoperable Chronic Thromboembolic Pulmonary Hypertension

(2008) Jay Suntharalingam et al.   CHEST

Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension

(2008) R. T. Schermuly et al.   EUROPEAN RESPIRATORY JOURNAL

Single-Dose Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of the Soluble Guanylate Cyclase Stimulator BAY 63-2521: An Ascending-Dose Study in Healthy Male Volunteers

(2008) Reiner Frey et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Bosentan for Treatment of Inoperable Chronic Thromboembolic Pulmonary Hypertension

(2008) Xavier Jaïs et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The NICE Cost-Effectiveness Threshold

(2008) Christopher McCabe et al.   PHARMACOECONOMICS